Skip to main content
. 2026 Aug 26;18(9):1068. doi: 10.3390/pharmaceutics18091068
DED Dry Eye Disease
RASP Reactive Aldehyde Species
RP Reproxalap
CD Cyclodextrin
α-CD Alpha-Cyclodextrin
β-CD Beta-Cyclodextrin
γ-CD Gamma-Cyclodextrin
HP-β-CD Hydroxypropyl-β-Cyclodextrin
SBE-β-CD Sulfobutyl Ether β-Cyclodextrin
RP: HP-β-CD IC Reproxalap Hydroxypropyl Ether β-Cyclodextrin Inclusion Complex
RP: SBE-β-CD IC Reproxalap Sulfobutyl Ether β-Cyclodextrin Inclusion Complex
RP: SBE-β-CD PM Reproxalap Sulfobutyl Ether β-Cyclodextrin Physical Mixture
RP: HP-β-CD PM Reproxalap Hydroxypropyl Ether β-Cyclodextrin Physical Mixture
P407 Poloxamer 407
HPLC High-Performance Liquid Chromatography
RP-HPLC Reverse-Phase High-Performance Liquid Chromatography
ICH International Council for Harmonisation
IUPAC International Union of Pure and Applied Chemistry